Effect of Mamsyadi kwatha ghana in the management of mild to moderate depression(vishaada)in adolescents

Efficacy of Mamsyadi kwatha ghana add on to cognitive behavioral therapy in the management of vishaada(mild to moderate depressive disorder)among adolescents- A Randomized double blind placebo controlled trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051925

Enrollment

Registered

2023-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F988- Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants showing signs of Mild to Moderate Depression as per DSM-V Criteria. (PHQ-9 score 5-14). 2. Participants whose caretakers/parents are willing to provide an informed consent. 3. Participants providing written informed assent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Patient having severe depression. 2. Patient having intelligent quotient below 70. 3. Patient having any severe co-morbid psychiatric disorder especially a diagnosis of bipolar disorder,schizophrenia, autism spectrum disorder, schizoaffective disorder or organic psychiatric disorder assessed by taking detailed history and examination. 4. Patient having any other medical or neurological conditions or any other illness interfering with interventions. 5. Participants suffering from any systemic illness, history of epilepsy or chronic illness like hypo or hyperthyroidism. 6. Substance use disorder or dependency, suicidal ideations. 7. Current use of Anti-epileptics, anti-psychotic or psychotropic drugs (e.g., Selective Serotonin Reuptake Inhibitor, Serotonin and norepinephrine reuptake inhibitors etc.) and any other investigational drugs.

Design outcomes

Primary

Measure	Time frame
Reduction in the PHQ-9 score.Timepoint: 0week,8weeks,16weeks	—

Secondary

Measure	Time frame
Improvement in sleep quality of adolescents as per PSQI scale Timepoint: 0week,8weeks,16weeks	—

Countries

India

Contacts

Public ContactDr Mahapatra Arun Kumar

All India Institute of Ayurveda

ayuarun@gmail.com8506821947

Outcome results